Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Katz, A. M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

PERSPECTIVE

The Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart

right arrow Arnold M. Katz

1 September 1994 | Volume 121 Issue 5 | Pages 363-371

Heart failure is a progressive condition with a 5-year survival of less than 50%. This poor prognosis, which can be reproduced by overloading the hearts of experimental animals, may reflect molecular abnormalities caused when overload stimulates adult cardiac myocytes to undergo hypertrophy. Because these terminally differentiated cells have little or no capacity to divide, hypertrophy represents an unnatural growth response; however, the mechanism by which overload shortens survival remains speculative. Modification of this unnatural growth response by converting enzyme inhibitors and nitrates, which have growth inhibitory as well as vasodilator effects, may contribute to the ability of these drugs to improve prognosis in patients with heart failure.

Author and Article Information
space

From the University of Connecticut School of Medicine, Farmington, Connecticut.
Requests for Reprints: Arnold M. Katz, MD, Cardiology Division, University of Connecticut Health Center, Farmington, CT 06030-1305.
Acknowledgments: The author thanks the Class of 1996 of the University of Connecticut Schools of Medicine and Dental Medicine for their interest in and enthusiasm for his lectures on this topic, which led to the preparation of this article; and James B. Young, MD, who pointed out the contribution of Austin Flint to our understanding of the importance of cardiac hypertrophy.
Grant Support: In part by Program Project HL-33026 from the National Heart, Lung, and Blood Institute.




This article has been cited by other articles:


Home page
Circ. Res.Home page
C. F.M.Z. Clemente, T. F. Tornatore, T. H. Theizen, A. C. Deckmann, T. C. Pereira, I. Lopes-Cendes, J. R. M. Souza, and K. G. Franchini
Targeting Focal Adhesion Kinase With Small Interfering RNA Prevents and Reverses Load-Induced Cardiac Hypertrophy in Mice
Circ. Res., December 7, 2007; 101(12): 1339 - 1348.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Koch, C. Geil-Bierschenk, R. Rieker, T. J. Dengler, F.-U. Sack, P. Schirmacher, S. Hagl, and P. A. Schnabel
Morphometric changes of the right ventricle in the first two weeks after clinical heart transplantation: analysis of myocardial biopsies from patients with complicated versus uncomplicated course.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 370 - 378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. S. Torsoni, T. M. Marin, L. A. Velloso, and K. G. Franchini
RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1488 - H1496.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. M. Fonseca, R. Y. Inoue, C. B. Kobarg, D. P. Crosara-Alberto, J. Kobarg, and K. G. Franchini
Targeting to C-Terminal Myosin Heavy Chain May Explain Mechanotransduction Involving Focal Adhesion Kinase in Cardiac Myocytes
Circ. Res., January 7, 2005; 96(1): 73 - 81.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Pilz, J.-H. Brasen, W. Schneider, and F. C. Luft
Obesity and Hypertension-Induced Restrictive Cardiomyopathy: A Harbinger of Things to Come
Hypertension, May 1, 2004; 43(5): 911 - 917.
[Full Text] [PDF]


Home page
Clin. DiabetesHome page
D. S.H. Bell
Heart Failure: A Serious and Common Comorbidity of Diabetes
Clin. Diabetes, April 1, 2004; 22(2): 61 - 65.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. S.H. Bell
Heart Failure: The frequent, forgotten, and often fatal complication of diabetes
Diabetes Care, August 1, 2003; 26(8): 2433 - 2441.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. S. Torsoni, S. S. Constancio, W. Nadruz Jr, S. K. Hanks, and K. G. Franchini
Focal Adhesion Kinase Is Activated and Mediates the Early Hypertrophic Response to Stretch in Cardiac Myocytes
Circ. Res., July 25, 2003; 93(2): 140 - 147.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Silverberg
Outcomes of anaemia management in renal insufficiency and cardiac disease
Nephrol. Dial. Transplant., June 1, 2003; 18(suppl_2): ii7 - ii12.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. K. Evans, D. D. Schwartz, and L. B. Gladden
Effect of myocardial volume overload and heart failure on lactate transport into isolated cardiac myocytes
J Appl Physiol, March 1, 2003; 94(3): 1169 - 1176.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Spyrou, S. D. Rosen, F. Fath-Ordoubadi, R. Jagathesan, R. Foale, J. S. Kooner, and P. G. Camici
Myocardial beta-adrenoceptor densityone month after acute myocardial infarctionpredicts left ventricular volumes at six months
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1216 - 1224.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Nemoto, M. Hamawaki, G. De Freitas, and B. A. Carabello
differential effects of the angiotensin-converting enzyme inhibitor lisinopril versus the beta-adrenergic receptor blocker atenolol on hemodynamics and left ventricular contractile function in experimental mitral regurgitation
J. Am. Coll. Cardiol., July 3, 2002; 40(1): 149 - 154.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Bartel, B. Hoch, D. Vetter, and E.-G. Krause
Expression of Human Angiotensinogen-Renin in Rat: Effects on Transcription and Heart Function
Hypertension, February 1, 2002; 39(2): 219 - 223.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. A. Fortuno, S. Ravassa, A. Fortuno, G. Zalba, and J. Diez
Cardiomyocyte Apoptotic Cell Death in Arterial Hypertension: Mechanisms and Potential Management
Hypertension, December 1, 2001; 38(6): 1406 - 1412.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. U Muller, P. Boknik, J. Knapp, B. Linck, H. Luss, J. Neumann, and W. Schmitz
Activation and inactivation of cAMP-response element-mediated gene transcription in cardiac myocytes
Cardiovasc Res, October 1, 2001; 52(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. Pons-Llado, M. Ballester, X. Borras, F. Carreras, I. Carrio, J. Lopez-Contreras, A. Roca-Cusachs, J. Marrugat, and J. Narula
Myocardial cell damage in human hypertension
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2198 - 2203.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. V. Cohen, X.-M. Yang, T. Neumann, G. Heusch, and J. M. Downey
Favorable Remodeling Enhances Recovery of Regional Myocardial Function in the Weeks After Infarction in Ischemically Preconditioned Hearts
Circulation, August 1, 2000; 102(5): 579 - 583.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. Kumar, D. R. Maurya, M. Chandra, S. Kumar, D. R. Maurya, and M. Chandra
ACE Inhibition Versus Angiotensin-II Antagonism in Heart Failure
Asian Cardiovasc Thorac Ann, June 1, 2000; 8(2): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. K. Brar, A. K. Jonassen, A. Stephanou, G. Santilli, J. Railson, R. A. Knight, D. M. Yellon, and D. S. Latchman
Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway
J. Biol. Chem., March 17, 2000; 275(12): 8508 - 8514.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Bartling, H. Milting, H. Schumann, D. Darmer, L. Arusoglu, M. M. Koerner, A. El-Banayosy, R. Koerfer, J. Holtz, and H.-R. Zerkowski
Myocardial Gene Expression of Regulators of Myocyte Apoptosis and Myocyte Calcium Homeostasis During Hemodynamic Unloading by Ventricular Assist Devices in Patients With End-Stage Heart Failure
Circulation, November 9, 1999; 100(90002): II-216 - 223.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Narula, P. Pandey, E. Arbustini, N. Haider, N. Narula, F. D. Kolodgie, B. Dal Bello, M. J. Semigran, A. Bielsa-Masdeu, G. W. Dec, et al.
Apoptosis in heart failure: Release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy
PNAS, July 6, 1999; 96(14): 8144 - 8149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. H. Sigal, P. Rajvanshi, G. R. Gorla, R. P. Sokhi, R. Saxena, D. R. Gebhard Jr., L. M. Reid, and S. Gupta
Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events
Am J Physiol Gastrointest Liver Physiol, May 1, 1999; 276(5): G1260 - G1272.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. V. Exner, D. L. Dries, M. A. Waclawiw, B. Shelton, and M. J. Domanski
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the studies of left ventricular dysfunction
J. Am. Coll. Cardiol., March 15, 1999; 33(4): 916 - 923.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Hupf, D. Grimm, G. A. J. Riegger, and H. Schunkert
Evidence for a Vasopressin System in the Rat Heart
Circ. Res., February 19, 1999; 84(3): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
F. U. Müller, P. Bokník, J. Knapp, J. Neumann, U. Vahlensieck, E. Oetjen, H. H. Scheld, and W. Schmitz
Identification and expression of a novel isoform of cAMP response element modulator in the human heart
FASEB J, September 1, 1998; 12(12): 1191 - 1199.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
Y.-T. Shen, R.T. Wiedmann, B.D. Greenland, J.J. Lynch, and W. Grossman
Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure
Cardiovasc Res, August 1, 1998; 39(2): 413 - 422.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Sakata, B. D. Hoit, S. B. Liggett, R. A. Walsh, and G. W. Dorn II
Decompensation of Pressure-Overload Hypertrophy in G{alpha}q-Overexpressing Mice
Circulation, April 21, 1998; 97(15): 1488 - 1495.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R P STEEDS and K S CHANNER
Heart failure: vive la difference!
Heart, December 1, 1997; 78(6): 537 - 538.
[Full Text] [PDF]


Home page
Circ. Res.Home page
T. Shioi, A. Matsumori, Y. Kihara, M. Inoko, K. Ono, Y. Iwanaga, T. Yamada, A. Iwasaki, K. Matsushima, and S. Sasayama
Increased Expression of Interleukin-1ß and Monocyte Chemotactic and Activating Factor/Monocyte Chemoattractant Protein-1 in the Hypertrophied and Failing Heart With Pressure Overload
Circ. Res., November 19, 1997; 81(5): 664 - 671.
[Abstract] [Full Text]


Home page
CirculationHome page
E. Missov, C. Calzolari, and B. Pau
Circulating Cardiac Troponin I in Severe Congestive Heart Failure
Circulation, November 4, 1997; 96(9): 2953 - 2958.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
T. Kubota, C. F. McTiernan, C. S. Frye, S. E. Slawson, B. H. Lemster, A. P. Koretsky, A. J. Demetris, and A. M. Feldman
Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-{alpha}
Circ. Res., October 19, 1997; 81(4): 627 - 635.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Matsumori, K. Ono, R. Nishio, Y. Nose, and S. Sasayama
Amiodarone Inhibits Production of Tumor Necrosis Factor-{alpha} by Human Mononuclear Cells : A Possible Mechanism for its Effect in Heart Failure
Circulation, September 2, 1997; 96(5): 1386 - 1389.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Matsumori, K. Ono, R. Nishio, H. Igata, B Pharm, T. Shioi, S. Matsui, Y. Furukawa, A. Iwasaki, Y. Nose, et al.
Modulation of Cytokine Production and Protection Against Lethal Endotoxemia by the Cardiac Glycoside Ouabain
Circulation, September 2, 1997; 96(5): 1501 - 1506.
[Abstract] [Full Text]


Home page
CirculationHome page
E. J. Eichhorn and M. R. Bristow
Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure
Circulation, November 1, 1996; 94(9): 2285 - 2296.
[Abstract] [Full Text]


Home page
NEJMHome page
J. Narula, N. Haider, R. Virmani, T. G. DiSalvo, F. D. Kolodgie, R. J. Hajjar, U. Schmidt, M. J. Semigran, G. W. Dec, and B.-A. Khaw
Apoptosis in Myocytes in End-Stage Heart Failure
N. Engl. J. Med., October 17, 1996; 335(16): 1182 - 1189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Peng, L. Huang, Z. Xie, W.-H. Huang, and A. Askari
Partial Inhibition of Na[IMAGE]/K[IMAGE]-ATPase by Ouabain Induces the Ca[IMAGE]-dependent Expressions of Early-response Genes in Cardiac Myocytes
J. Biol. Chem., April 26, 1996; 271(17): 10372 - 10378.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. U. Muller, P. Boknik, A. Horst, J. Knapp, B. Linck, W. Schmitz, U. Vahlensieck, M. Bohm, M. C. Deng, and H. H. Scheld
cAMP Response Element Binding Protein Is Expressed and Phosphorylated in the Human Heart
Circulation, October 15, 1995; 92(8): 2041 - 2043.
[Abstract] [Full Text]


Home page
CirculationHome page
A. M. Katz and P. B. Katz
Emergence of Scientific Explanations of Nature in Ancient Greece : The Only Scientific Discovery?
Circulation, August 1, 1995; 92(3): 637 - 645.
[Full Text]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1994 by the American College of Physicians.